EP4522138A4 - Filmtablette mit linagliptin - Google Patents

Filmtablette mit linagliptin

Info

Publication number
EP4522138A4
EP4522138A4 EP23803955.6A EP23803955A EP4522138A4 EP 4522138 A4 EP4522138 A4 EP 4522138A4 EP 23803955 A EP23803955 A EP 23803955A EP 4522138 A4 EP4522138 A4 EP 4522138A4
Authority
EP
European Patent Office
Prior art keywords
film
coated tablet
tablet containing
containing linagliptin
linagliptin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23803955.6A
Other languages
English (en)
French (fr)
Other versions
EP4522138A2 (de
Inventor
Neyir Zeynep Taskent
Muhammed Emre Kara
Demet Ulker
Isa Albayrak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atabay Kimya Sanayi Ve Tic AS
Atabay Kimya Sanayi Ve Tic A S
Original Assignee
Atabay Kimya Sanayi Ve Tic AS
Atabay Kimya Sanayi Ve Tic A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atabay Kimya Sanayi Ve Tic AS, Atabay Kimya Sanayi Ve Tic A S filed Critical Atabay Kimya Sanayi Ve Tic AS
Priority claimed from PCT/TR2023/050422 external-priority patent/WO2023219591A2/en
Publication of EP4522138A2 publication Critical patent/EP4522138A2/de
Publication of EP4522138A4 publication Critical patent/EP4522138A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
EP23803955.6A 2022-05-09 2023-05-08 Filmtablette mit linagliptin Pending EP4522138A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR202207542 2022-05-09
PCT/TR2023/050422 WO2023219591A2 (en) 2022-05-09 2023-05-08 Film-coated tablet containing linagliptin

Publications (2)

Publication Number Publication Date
EP4522138A2 EP4522138A2 (de) 2025-03-19
EP4522138A4 true EP4522138A4 (de) 2026-05-06

Family

ID=94686904

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23803955.6A Pending EP4522138A4 (de) 2022-05-09 2023-05-08 Filmtablette mit linagliptin

Country Status (1)

Country Link
EP (1) EP4522138A4 (de)

Also Published As

Publication number Publication date
EP4522138A2 (de) 2025-03-19

Similar Documents

Publication Publication Date Title
CA227259S (en) Pill organizer
IL279299A (en) A tablet coated with a layer containing a derivative of triazine for use in the treatment of diabetes
CA220303S (en) Pill holder
GB2606052B (en) Tablet holder
EP4522138A4 (de) Filmtablette mit linagliptin
CA229693S (en) Pill organizer
EP4115870A4 (de) Tablettkassette
ZA202311082B (en) A tablet composition
CA235950S (en) Tablet
CA218485S (en) Tablet stand
PH32023050572S1 (en) Tablet
CA226801S (en) Pill organizer
CA211410S (en) Pill organizer
CA234325S (en) Coffee tablet
CA234328S (en) Coffee tablet
CA234326S (en) Coffee tablet
CA234324S (en) Coffee tablet
CA234323S (en) Coffee tablet
CA221286S (en) Pill
CA224207S (en) Computer tablet
CA233333S (en) Pharmaceutical tablet
CA233334S (en) Pharmaceutical tablet
CA222831S (en) Tablet computer
CA215794S (en) Tablet computer
CA215795S (en) Tablet computer

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20241205

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0031155000

Ipc: A61K0009200000